STAGE IIB PROSTATE CANCER AJCC V8
Clinical trials for STAGE IIB PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIB PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach may offer shorter, safer treatment for recurrent prostate cancer
Disease control Recruiting nowThis study tests whether a precise, short-course radiation method (SBRT) works as well as a slightly longer radiation approach (hypofractionated radiotherapy) for men whose prostate cancer has come back or spread to a few spots after surgery. About 118 participants will receive o…
Matched conditions: STAGE IIB PROSTATE CANCER AJCC V8
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New scan could spot hidden aggressive prostate cancer in men who think They're safe
Diagnosis Recruiting nowThis study tests whether a special PET-MRI scan using a radioactive tracer called rhPSMA-7.3 can find higher-risk prostate cancer that standard tests might miss. Men with low-risk or favorable intermediate-risk prostate cancer who are candidates for active surveillance will recei…
Matched conditions: STAGE IIB PROSTATE CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
Heart showdown: which prostate cancer drug is kinder to your heart?
Knowledge-focused Recruiting nowThis study compares two hormone-lowering drugs, Orgovyx and Eligard, in men with prostate cancer who are also getting radiation therapy. The goal is to see which drug has less impact on heart function and overall heart health. About 70 participants will undergo heart tests, exerc…
Matched conditions: STAGE IIB PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC